Company / CapEx per Share
BioAge Labs, Inc. CapEx per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $0.10
FY2023-FY2025
Trend
-41.2%
vs FY2024
Sector context
#105 of 192
Health Care
What the data says
At $0.02, BioAge Labs, Inc.'s capex per share ranks #105 of 192 in the Health Care sector. Declined from $0.10 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2025.
Declined from $0.10 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 192 in Health CareTop 55% of 192This company $0.02 Sector average $3.54
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 41.2% year-over-year.
- Ranks #105 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -41.2% |
| FY2024 | $0.03 | -65.6% |
| FY2023 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026